|S.No.||Company Name||Short Description||No of Drugs||Company Drug Price||Action|
|1||Jhonshon & Jhonson||Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.||4||50.00||BUY||Your Query|
|S.No.||Updated On||Drug||Price in USD||Action|
|1||Apr, 2020||Imbruvica Drug Sales & Forecast|
Johnson & Johnson drug Imbruvica (ibrutinib) is an oral, once-daily medicine that works differently than chemotherapy as it blocks a protein called Bruton....
|2||Apr, 2020||Stelara Drug Sales & Forecast|
Johnson & Johnson drug Stelara (ustekinumab), a treatment for adults and children with moderate to severe plaque psoriasis, for adults with active psoriat....
|3||Apr, 2020||Darzalex Drug Sales & Forecast|
Johnson & Johnson drug Darzalex (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. Darzalex is not che....
|4||Apr, 2020||Erleada Drug Sales & Forecast|
Johnson & Johnson drug Erleada (apalutamide) is an androgen receptor (AR) inhibitor indicated for the treatment of patients with non-metastatic castration....